Soundscape Evaluation of a Heritage Event in an Open Environment: The Water Tribunal of the Plain of Valencia (Spain)

[EN] The acoustic evaluation of indoor environments is common in the application of virtual acoustics. In addition, in the study of cultural heritage buildings, it is a useful tool, but it is not so common when describing the acoustic environment in intangible cultural heritage events and even in outdoor environments. In this paper, the acoustic environment of the Water Tribunal of the Plain of Valencia (Spain) is studied. It is analyzed from a soundscape perspective, characterizing the sound source and evaluating it within relation to the environment and evaluating its subjective response. With the research carried out, it has been obtained, on the one hand, a complete study of the acoustics of the environment of the Water Tribunal and, on the other, an enhancement of the Valencian tangible and intangible heritage.This research was partially funded by Spanish Ministry of Science, Innovation and Universities, grant number BIA2016-76957-C3-3-R and by the Universitat de Valencia with the grant UV-INV-AE-1550319.Díaz-Rubio, E.; Segura-Garcia, J.; Fayos-Jordan, R.; Cerdá, S.; Cibrián, RM.; Giménez Pérez, A. (2022). Soundscape Evaluation of a Heritage Event in an Open Environment: The Water Tribunal of the Plain of Valencia (Spain). Applied Sciences. 12(9):1-17. https://doi.org/10.3390/app1209429211712

Stainless steel corrosion in instrumentation pipe

Corrosion, being a destructive process, causes damage in almost all industrial sectors. In this way, it is harmful both from an economic, social and, especially, safety point of view, as it can cause failures in critical equipment and components of an industrial process. At this point, stainless steels are considered the most corrosion resistant metals. The resistance depends on the chemical composition and microstructure, factors that directly influence the passivation of these materials. The resistance is proportionally related to the addition of chromium (Cr) to the mixture, as well as other alloying elements, among which is the molybdenum (Mo), whose main function is to maximize corrosion resistance in the marine atmosphere, as in case of austenitic stainless steel AISI 316 which presents in the chemical composition a percentage of the element Mo. Austenitic stainless steels are applied in instrumentation systems in tubing for reliability in severe atmospheres in accordance with ASTM A269 which establishes the materials applicable to this function. Thus, the present work presents, through a review and case study, Pitting Corrosion of tubings of austenitic stainless steel AISI 316 in the presence of chloride ions (Cl-) coming from the marine atmosphere. The results show that there is no change in the longitudinal and transverse structure for all analyzed tubes, showing a homogeneous austenitic structure, free of intergranular precipitations

Overexpression of CYB5R3 and NQO1, Two NAD\u3csup\u3e+\u3c/sup\u3e-Producing Enzymes, Mimics Aspects of Caloric Restriction

Calorie restriction (CR) is one of the most robust means to improve health and survival in model organisms. CR imposes a metabolic program that leads to increased stress resistance and delayed onset of chronic diseases, including cancer. In rodents, CR induces the upregulation of two NADH‐dehydrogenases, namely NAD(P)H:quinone oxidoreductase 1 (Nqo1) and cytochrome b5 reductase 3 (Cyb5r3), which provide electrons for energy metabolism. It has been proposed that this upregulation may be responsible for some of the beneficial effects of CR, and defects in their activity are linked to aging and several age‐associated diseases. However, it is unclear whether changes in metabolic homeostasis solely through upregulation of these NADH‐dehydrogenases have a positive impact on health and survival. We generated a mouse that overexpresses both metabolic enzymes leading to phenotypes that resemble aspects of CR including a modest increase in lifespan, greater physical performance, a decrease in chronic inflammation, and, importantly, protection against carcinogenesis, one of the main hallmarks of CR. Furthermore, these animals showed an enhancement of metabolic flexibility and a significant upregulation of the NAD+/sirtuin pathway. The results highlight the importance of these NAD+ producers for the promotion of health and extended lifespan

Clinical characteristics and respiratory care in hospitalized vaccinated SARS-CoV-2 patients

Background: The main objective of the present study was to analyze both clinical characteristics and evolution during hospitalization of a cohort of patients admitted for COVID-19 pneumonia who were not vaccinated, or with a complete or incomplete vaccination schedule. Methods: This COVID-19 specialized single-center cohort study of 1888 COVID-19 patients hospitalized at the “Enfermera Isabel Zendal” Emergencies Hospital (HEEIZ), Madrid (Spain) was performed between July 1 and September 30, 2021. It compared the results of 1327 hospitalized unvaccinated patients to 209 hospitalized fully vaccinated and 352 hospitalized partially vaccinated patients. The four different COVID-19 vaccines authorized in Spain during the time-period studied were: BNT162b2 (Pfizer); ChAdOx1 nCoV-19 (AstraZeneca), mRNA-1273 (Moderna); Ad26.COV2.S (Janssen). Findings: Hospitalized patients’ median age was 41 years (IQR 33–50) for the unvaccinated and 61 years (IQR 53–67) for the fully vaccinated ones. The main comorbidities were obesity, hypertension and diabetes mellitus. 20% of unvaccinated patients (266) required noninvasive respiratory care, as did 14% (51) of partially and 14% (30) of fully vaccinated; 6% (78) of the unvaccinated patients also needed invasive respiratory care, as did 5% (16) of partially and 11 (5%) fully vaccinated. Interpretation: Fully vaccinated patients were 84% (95% CI: 82–86%) less likely to be admitted to hospital, and protection rose for those aged <50 years. Once hospitalized, vaccinated patients displayed more protection against requiring respiratory care than unvaccinated ones, despite being older and having more comorbidities. No differences appeared for the four studied COVID-19 vaccines and complying with vaccination recommendations proved relevant. Funding: The research was funded by the “Plan Propio de Investigación” Program of the Castilla-La Mancha University /European Regional Development Fund (2021-GRIN-31,039

Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004–2013

SummaryObjectivesTo analyze the impact of late presentation (LP) on overall mortality and causes of death and describe LP trends and risk factors (2004–2013).MethodsCox models and logistic regression were used to analyze data from a nation-wide cohort in Spain. LP is defined as being diagnosed when CD4 < 350 cells/ml or AIDS.ResultsOf 7165 new HIV diagnoses, 46.9% (CI95%:45.7–48.0) were LP, 240 patients died.First-year mortality was the highest (aHRLP.vs.nLP = 10.3[CI95%:5.5–19.3]); between 1 and 4 years post-diagnosis, aHRLP.vs.nLP = 1.9(1.2–3.0); and >4 years, aHRLP.vs.nLP = 1.5(0.7–3.1).First-year's main cause of death was HIV/AIDS (73%); and malignancies among those surviving >4 years (32%). HIV/AIDS-related deaths were more likely in LP (59.2% vs. 25.0%; p < 0.001). LP declined from 55.9% (2004–05) to 39.4% (2012–13), and reduced in 46.1% in men who have sex with men (MSM) and 37.6% in heterosexual men, but increased in 22.6% in heterosexual women.Factors associated with LP: sex (ORMEN.vs.WOMEN = 1.4[1.2–1.7]); age (OR31–40.vs.<30 = 1.6[1.4–1.8], OR41–50.vs.<30 = 2.2[1.8–2.6], OR>50.vs.<30 = 3.6[2.9–4.4]); behavior (ORInjectedDrugUse.vs.MSM = 2.8[2.0–3.8]; ORHeterosexual.vs.MSM = 2.2[1.7–3.0]); education (ORPrimaryEducation.vs.University = 1.5[1.1–2.0], ORLowerSecondary.vs.University = 1.3[1.1–1.5]); and geographical origin (ORSub-Saharan.vs.Spain = 1.6[1.3–2.0], ORLatin-American.vs.Spain = 1.4[1.2–1.8]).ConclusionsLP is associated with higher mortality, especially short-term- and HIV/AIDS-related mortality. Mid-term-, but not long-term mortality, remained also higher in LP than nLP. LP decreased in MSM and heterosexual men, not in heterosexual women. The groups most affected by LP are low educated, non-Spanish and heterosexual women

Metodología para la mejora acústica de recintos de culto. Aplicación en la Catedral de Valencia

[ES] Los recintos de culto son espacios patrimoniales de gran valor cultural, artístico y arquitectónico. Asimismo, en ellos tienen lugar eventos, integrantes de su patrimonio cultural inmaterial, donde la transmisión del sonido es un factor preferente. Por todo ello, resulta relevante garantizar un adecuado acondicionamiento acústico de los recintos de culto para sus dos usos fundamentales, la música religiosa y la palabra. Para ello, se ha establecido una metodología compuesta por las fases de medición acústica, estudio del comportamiento acústico del recinto, levantamiento y calibración del modelo acústico y simulaciones acústicas. Al tratarse de edificios protegidos, las propuestas de intervención deben basarse en el respeto a los valores patrimoniales de los templos. Con todo ello, en este estudio se ha realizado una propuesta de mejora del acondicionamiento acústico de la Catedral de Valencia.[EN] Places of worship are heritage spaces of great cultural, artistic and architectural value. Likewise, events take place in them, members of their intangible cultural heritage, where the transmission of sound is a preferential factor. Therefore, it is important to guarantee an adequate acoustic conditioning of the places of worship for its two fundamental uses, religious music and speech. For this, a methodology has been established consisting of the phases of acoustic measurement, study of the acoustic behavior of the enclosure, lifting and calibration of the acoustic model and acoustic simulations. As they are protected buildings, intervention proposals must be based on respect for the heritage values of temples. With all this, in this study a proposal has been made to improve the acoustic conditioning of the Cathedral of Valencia.Este estudio ha sido subvencionado por el Ministerio de Ciencia e Innovación a través de los proyectos de investigación BIA2012-36896 y BIA2016-76957-C3-3-RDíaz-Rubio, E.; Montell Serrano, RE.; Cerdá Jordá, S.; Segura Garcia, J.; Cibrián Ortíz De Anda, R.; Barba Sevillano, A.; Lacatis, RG.... (2021). Metodología para la mejora acústica de recintos de culto. Aplicación en la Catedral de Valencia. Revista de Acústica. 52(3 y 4):49-57. http://hdl.handle.net/10251/180498S4957523 y

Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma

The mechanisms triggering metastasis in pheochromocytoma/paraganglioma are unknown, hindering therapeutic options for patients with metastatic tumors (mPPGL). Herein we show by genomic profiling of a large cohort of mPPGLs that high mutational load, microsatellite instability and somatic copy-number alteration burden are associated with ATRX/TERT alterations and are suitable prognostic markers. Transcriptomic analysis defines the signaling networks involved in the acquisition of metastatic competence and establishes a gene signature related to mPPGLs, highlighting CDK1 as an additional mPPGL marker. Immunogenomics accompanied by immunohistochemistry identifies a heterogeneous ecosystem at the tumor microenvironment level, linked to the genomic subtype and tumor behavior. Specifically, we define a general immunosuppressive microenvironment in mPPGLs, the exception being PD-L1 expressing MAML3-related tumors. Our study reveals canonical markers for risk of metastasis, and suggests the usefulness of including immune parameters in clinical management for PPGL prognostication and identification of patients who might benefit from immunotherapy

A short-term study of the safety pharmacokinetics and efficacy of ritonavir, an inhibitor of HIV-1 protease

Background: Reverse-transcriptase inhibitors have only moderate clinical efficacy against the human immunodeficiency virus type 1 (HIV-1). Ritonavir is an inhibitor of HIV-1 protease with potent in vitro anti-HIV properties and good oral bioavailability. Methods: We evaluated the antiviral activity and safety of ritonavir in a double-blind, randomized, placebo-controlled phase 1 and 2 study of 84 HIV-positive patients with 50 or more CD4+ lymphocytes per cubic millimeter. The patients were randomly assigned to one of four regimens of ritonavir therapy, or to placebo for four weeks and then (by random assignment) to one of the ritonavir regimens. Results: During the first 4 weeks, increases in CD4+ lymphocyte counts and reductions in the log number of copies of HIV-1 RNA per milliliter of plasma were similar among the four dosage groups, but in the three lower-dosage groups there was a return to base-line levels by 16 weeks. After 32 weeks, in the seven patients in the highest-dosage group (600 mg of ritonavir every 12 hours), the median increase from base line in the CD4+ lymphocyte count was 230 cells per cubic millimeter, and the mean decrease in the plasma concentration of HIV-1 RNA (as measured by a branched-chain DNA assay) was 0.81 log (95 percent confidence interval, 0.40 to 1.22). In a subgroup of 17 patients in the two higher-dosage groups, RNA was also measured with an assay based on the polymerase chain reaction, and after eight weeks of treatment there was a mean maximal decrease in viral RNA of 1.94 log (95 percent confidence interval, 1.37 to 2.51). Adverse events included nausea, circumoral paresthesia, elevated hepatic aminotransferase levels, and elevated triglyceride levels. Ten withdrawals from the study were judged to be related to ritonavir treatment. Conclusions: In this short-term study, ritonavir was well tolerated and had potent activity against HIV-1, but its clinical benefits remain to be established